Skip to main content
PMC home page
Microbiology and Molecular Biology Reviews : MMBR logoLink to Microbiology and Molecular Biology Reviews : MMBR
. 1997 Sep;61(3):377–392. doi: 10.1128/mmbr.61.3.377-392.1997

DNA gyrase, topoisomerase IV, and the 4-quinolones.

K Drlica 1, X Zhao 1
PMCID: PMC232616  PMID: 9293187

Abstract

For many years, DNA gyrase was thought to be responsible both for unlinking replicated daughter chromosomes and for controlling negative superhelical tension in bacterial DNA. However, in 1990 a homolog of gyrase, topoisomerase IV, that had a potent decatenating activity was discovered. It is now clear that topoisomerase IV, rather than gyrase, is responsible for decatenation of interlinked chromosomes. Moreover, topoisomerase IV is a target of the 4-quinolones, antibacterial agents that had previously been thought to target only gyrase. The key event in quinolone action is reversible trapping of gyrase-DNA and topoisomerase IV-DNA complexes. Complex formation with gyrase is followed by a rapid, reversible inhibition of DNA synthesis, cessation of growth, and induction of the SOS response. At higher drug concentrations, cell death occurs as double-strand DNA breaks are released from trapped gyrase and/or topoisomerase IV complexes. Repair of quinolone-induced DNA damage occurs largely via recombination pathways. In many gram-negative bacteria, resistance to moderate levels of quinolone arises from mutation of the gyrase A protein and resistance to high levels of quinolone arises from mutation of a second gyrase and/or topoisomerase IV site. For some gram-positive bacteria, the situation is reversed: primary resistance occurs through changes in topoisomerase IV while gyrase changes give additional resistance. Gyrase is also trapped on DNA by lethal gene products of certain large, low-copy-number plasmids. Thus, quinolone-topoisomerase biology is providing a model for understanding aspects of host-parasite interactions and providing ways to investigate manipulation of the bacterial chromosome by topoisomerases.

Full Text

The Full Text of this article is available as a PDF (278.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. E., Shekhtman E. M., Zechiedrich E. L., Schmid M. B., Cozzarelli N. R. The role of topoisomerase IV in partitioning bacterial replicons and the structure of catenated intermediates in DNA replication. Cell. 1992 Oct 16;71(2):277–288. doi: 10.1016/0092-8674(92)90356-h. [DOI] [PubMed] [Google Scholar]
  2. Alangaden G. J., Manavathu E. K., Vakulenko S. B., Zvonok N. M., Lerner S. A. Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrob Agents Chemother. 1995 Aug;39(8):1700–1703. doi: 10.1128/aac.39.8.1700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bailone A., Sommer S., Devoret R. Mini-F plasmid-induced SOS signal in Escherichia coli is RecBC dependent. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5973–5977. doi: 10.1073/pnas.82.17.5973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Belland R. J., Morrison S. G., Ison C., Huang W. M. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol. 1994 Oct;14(2):371–380. doi: 10.1111/j.1365-2958.1994.tb01297.x. [DOI] [PubMed] [Google Scholar]
  5. Berger J. M., Gamblin S. J., Harrison S. C., Wang J. C. Structure and mechanism of DNA topoisomerase II. Nature. 1996 Jan 18;379(6562):225–232. doi: 10.1038/379225a0. [DOI] [PubMed] [Google Scholar]
  6. Bernard P., Couturier M. Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J Mol Biol. 1992 Aug 5;226(3):735–745. doi: 10.1016/0022-2836(92)90629-x. [DOI] [PubMed] [Google Scholar]
  7. Bernard P., Couturier M. The 41 carboxy-terminal residues of the miniF plasmid CcdA protein are sufficient to antagonize the killer activity of the CcdB protein. Mol Gen Genet. 1991 Apr;226(1-2):297–304. doi: 10.1007/BF00273616. [DOI] [PubMed] [Google Scholar]
  8. Bernard P., Kézdy K. E., Van Melderen L., Steyaert J., Wyns L., Pato M. L., Higgins P. N., Couturier M. The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. J Mol Biol. 1993 Dec 5;234(3):534–541. doi: 10.1006/jmbi.1993.1609. [DOI] [PubMed] [Google Scholar]
  9. Blanche F., Cameron B., Bernard F. X., Maton L., Manse B., Ferrero L., Ratet N., Lecoq C., Goniot A., Bisch D. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Antimicrob Agents Chemother. 1996 Dec;40(12):2714–2720. doi: 10.1128/aac.40.12.2714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Breines D. M., Ouabdesselam S., Ng E. Y., Tankovic J., Shah S., Soussy C. J., Hooper D. C. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrob Agents Chemother. 1997 Jan;41(1):175–179. doi: 10.1128/aac.41.1.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Béjar S., Bouché J. P. The spacing of Escherichia coli DNA gyrase sites cleaved in vivo by treatment with oxolinic acid and sodium dodecyl sulfate. Biochimie. 1984 Nov-Dec;66(11-12):693–700. doi: 10.1016/0300-9084(84)90258-x. [DOI] [PubMed] [Google Scholar]
  12. Camacho-Carranza R., Membrillo-Hernández J., Ramírez-Santos J., Castro-Dorantes J., Chagoya de Sánchez V., Gómez-Eichelmann M. C. Topoisomerase activity during the heat shock response in Escherichia coli K-12. J Bacteriol. 1995 Jun;177(12):3619–3622. doi: 10.1128/jb.177.12.3619-3622.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chaudhury A. M., Smith G. R. Role of Escherichia coli RecBC enzyme in SOS induction. Mol Gen Genet. 1985;201(3):525–528. doi: 10.1007/BF00331350. [DOI] [PubMed] [Google Scholar]
  14. Chen A. Y., Liu L. F. DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol. 1994;34:191–218. doi: 10.1146/annurev.pa.34.040194.001203. [DOI] [PubMed] [Google Scholar]
  15. Chen C. R., Malik M., Snyder M., Drlica K. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J Mol Biol. 1996 May 17;258(4):627–637. doi: 10.1006/jmbi.1996.0274. [DOI] [PubMed] [Google Scholar]
  16. Chow R. T., Dougherty T. J., Fraimow H. S., Bellin E. Y., Miller M. H. Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12. Antimicrob Agents Chemother. 1988 Aug;32(8):1113–1118. doi: 10.1128/aac.32.8.1113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Coll R., Gargallo-Viola D., Tudela E., Xicota M. A., Llovera S., Guinea J. Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones. Antimicrob Agents Chemother. 1996 Jan;40(1):274–277. doi: 10.1128/aac.40.1.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Craig N. L., Roberts J. W. E. coli recA protein-directed cleavage of phage lambda repressor requires polynucleotide. Nature. 1980 Jan 3;283(5742):26–30. doi: 10.1038/283026a0. [DOI] [PubMed] [Google Scholar]
  19. Critchlow S. E., Maxwell A. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex. Biochemistry. 1996 Jun 11;35(23):7387–7393. doi: 10.1021/bi9603175. [DOI] [PubMed] [Google Scholar]
  20. Crumplin G. C., Smith J. T. Nalidixic acid: an antibacterial paradox. Antimicrob Agents Chemother. 1975 Sep;8(3):251–261. doi: 10.1128/aac.8.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cullis P. M., Maxwell A., Weiner D. P. Exploiting nucleotide thiophosphates to probe mechanistic aspects of Escherichia coli DNA gyrase. Biochemistry. 1997 May 20;36(20):6059–6068. doi: 10.1021/bi962725e. [DOI] [PubMed] [Google Scholar]
  22. D'Arpa P., Beardmore C., Liu L. F. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 1990 Nov 1;50(21):6919–6924. [PubMed] [Google Scholar]
  23. Davagnino J., Herrero M., Furlong D., Moreno F., Kolter R. The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine. Proteins. 1986 Nov;1(3):230–238. doi: 10.1002/prot.340010305. [DOI] [PubMed] [Google Scholar]
  24. Deguchi T., Yasuda M., Nakano M., Ozeki S., Ezaki T., Saito I., Kawada Y. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother. 1996 Apr;40(4):1020–1023. doi: 10.1128/aac.40.4.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Deitz W. H., Cook T. M., Goss W. A. Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality. J Bacteriol. 1966 Feb;91(2):768–773. doi: 10.1128/jb.91.2.768-773.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. DiNardo S., Voelkel K. A., Sternglanz R., Reynolds A. E., Wright A. Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes. Cell. 1982 Nov;31(1):43–51. doi: 10.1016/0092-8674(82)90403-2. [DOI] [PubMed] [Google Scholar]
  27. Dorman C. J., Barr G. C., Ni Bhriain N., Higgins C. F. DNA supercoiling and the anaerobic and growth phase regulation of tonB gene expression. J Bacteriol. 1988 Jun;170(6):2816–2826. doi: 10.1128/jb.170.6.2816-2826.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Dorman C. J., Lynch A. S., Ni Bhriain N., Higgins C. F. DNA supercoiling in Escherichia coli: topA mutations can be suppressed by DNA amplifications involving the tolC locus. Mol Microbiol. 1989 Apr;3(4):531–540. doi: 10.1111/j.1365-2958.1989.tb00199.x. [DOI] [PubMed] [Google Scholar]
  29. Drlica K., Engle E. C., Manes S. H. DNA gyrase on the bacterial chromosome: possibility of two levels of action. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6879–6883. doi: 10.1073/pnas.77.11.6879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Drlica K., Snyder M. Superhelical Escherichia coli DNA: relaxation by coumermycin. J Mol Biol. 1978 Apr 5;120(2):145–154. doi: 10.1016/0022-2836(78)90061-x. [DOI] [PubMed] [Google Scholar]
  31. Drlica K., Xu C., Wang J. Y., Burger R. M., Malik M. Fluoroquinolone action in mycobacteria: similarity with effects in Escherichia coli and detection by cell lysate viscosity. Antimicrob Agents Chemother. 1996 Jul;40(7):1594–1599. doi: 10.1128/aac.40.7.1594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Engle E. C., Manes S. H., Drlica K. Differential effects of antibiotics inhibiting gyrase. J Bacteriol. 1982 Jan;149(1):92–98. doi: 10.1128/jb.149.1.92-98.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Esposito F., Sinden R. R. Supercoiling in prokaryotic and eukaryotic DNA: changes in response to topological perturbation of plasmids in E. coli and SV40 in vitro, in nuclei and in CV-1 cells. Nucleic Acids Res. 1987 Jul 10;15(13):5105–5124. doi: 10.1093/nar/15.13.5105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Fan J. Y., Sun D., Yu H., Kerwin S. M., Hurley L. H. Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex. J Med Chem. 1995 Feb 3;38(3):408–424. doi: 10.1021/jm00003a003. [DOI] [PubMed] [Google Scholar]
  35. Ferrero L., Cameron B., Crouzet J. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother. 1995 Jul;39(7):1554–1558. doi: 10.1128/aac.39.7.1554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ferrero L., Cameron B., Manse B., Lagneaux D., Crouzet J., Famechon A., Blanche F. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol Microbiol. 1994 Aug;13(4):641–653. doi: 10.1111/j.1365-2958.1994.tb00458.x. [DOI] [PubMed] [Google Scholar]
  37. Filutowicz M., Jonczyk P. The gyrB gene product functions in both initiation and chain polymerization of Escherichia coli chromosome replication: suppression of the initiation deficiency in gyrB-ts mutants by a class of rpoB mutations. Mol Gen Genet. 1983;191(2):282–287. doi: 10.1007/BF00334827. [DOI] [PubMed] [Google Scholar]
  38. Fisher L. M., Mizuuchi K., O'Dea M. H., Ohmori H., Gellert M. Site-specific interaction of DNA gyrase with DNA. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4165–4169. doi: 10.1073/pnas.78.7.4165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Forsyth M. H., Sayed A. S., Geary S. J. Sequence and transcriptional analysis of the genes encoding the class-II topoisomerase of Mycoplasma gallisepticum. Gene. 1995 Sep 22;163(1):161–162. doi: 10.1016/0378-1119(95)00440-h. [DOI] [PubMed] [Google Scholar]
  40. Friedman S. M., Malik M., Drlica K. DNA supercoiling in a thermotolerant mutant of Escherichia coli. Mol Gen Genet. 1995 Aug 30;248(4):417–422. doi: 10.1007/BF02191641. [DOI] [PubMed] [Google Scholar]
  41. GOSS W. A., DEITZ W. H., COOK T. M. MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI.II. INHIBITION OF DEOXYRIBONUCLEIC ACID SYNTHESIS. J Bacteriol. 1965 Apr;89:1068–1074. doi: 10.1128/jb.89.4.1068-1074.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Garrido M. C., Herrero M., Kolter R., Moreno F. The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell. EMBO J. 1988 Jun;7(6):1853–1862. doi: 10.1002/j.1460-2075.1988.tb03018.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Garí E., Figueroa-Bossi N., Blanc-Potard A. B., Spirito F., Schmid M. B., Bossi L. A class of gyrase mutants of Salmonella typhimurium show quinolone-like lethality and require rec functions for viability. Mol Microbiol. 1996 Jul;21(1):111–122. doi: 10.1046/j.1365-2958.1996.6221338.x. [DOI] [PubMed] [Google Scholar]
  44. Gellert M., Menzel R., Mizuuchi K., O'Dea M. H., Friedman D. I. Regulation of DNA supercoiling in Escherichia coli. Cold Spring Harb Symp Quant Biol. 1983;47(Pt 2):763–767. doi: 10.1101/sqb.1983.047.01.087. [DOI] [PubMed] [Google Scholar]
  45. Gellert M., Mizuuchi K., O'Dea M. H., Itoh T., Tomizawa J. I. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci U S A. 1977 Nov;74(11):4772–4776. doi: 10.1073/pnas.74.11.4772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Gellert M., Mizuuchi K., O'Dea M. H., Nash H. A. DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci U S A. 1976 Nov;73(11):3872–3876. doi: 10.1073/pnas.73.11.3872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Georgiou M., Muñoz R., Román F., Cantón R., Gómez-Lus R., Campos J., De La Campa A. G. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob Agents Chemother. 1996 Jul;40(7):1741–1744. doi: 10.1128/aac.40.7.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Goldmark P. J., Linn S. An endonuclease activity from Escherichia coli absent from certain rec- strains. Proc Natl Acad Sci U S A. 1970 Sep;67(1):434–441. doi: 10.1073/pnas.67.1.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Goldstein E., Drlica K. Regulation of bacterial DNA supercoiling: plasmid linking numbers vary with growth temperature. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4046–4050. doi: 10.1073/pnas.81.13.4046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Grau R., Gardiol D., Glikin G. C., de Mendoza D. DNA supercoiling and thermal regulation of unsaturated fatty acid synthesis in Bacillus subtilis. Mol Microbiol. 1994 Mar;11(5):933–941. doi: 10.1111/j.1365-2958.1994.tb00372.x. [DOI] [PubMed] [Google Scholar]
  51. Green M. H., Donch J., Greenberg J. Effect of inhibitors of DNA synthesis of UV-sensitive derivatives of Escherichia coli strain K-12. Mutat Res. 1970 Feb;9(2):149–154. doi: 10.1016/0027-5107(70)90053-9. [DOI] [PubMed] [Google Scholar]
  52. Griggs D. J., Gensberg K., Piddock L. J. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother. 1996 Apr;40(4):1009–1013. doi: 10.1128/aac.40.4.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Gudas L. J., Pardee A. B. DNA synthesis inhibition and the induction of protein X in Escherichia coli. J Mol Biol. 1976 Mar 15;101(4):459–477. doi: 10.1016/0022-2836(76)90240-0. [DOI] [PubMed] [Google Scholar]
  54. Guillemin I., Cambau E., Jarlier V. Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones. Antimicrob Agents Chemother. 1995 Sep;39(9):2145–2149. doi: 10.1128/aac.39.9.2145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Hane M. W., Wood T. H. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. J Bacteriol. 1969 Jul;99(1):238–241. doi: 10.1128/jb.99.1.238-241.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hayakawa I., Atarashi S., Yokohama S., Imamura M., Sakano K., Furukawa M. Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother. 1986 Jan;29(1):163–164. doi: 10.1128/aac.29.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother. 1996 Apr;40(4):879–885. doi: 10.1128/aac.40.4.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Heisig P. High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. J Antimicrob Chemother. 1993 Sep;32(3):367–377. doi: 10.1093/jac/32.3.367. [DOI] [PubMed] [Google Scholar]
  59. Heisig P., Wiedemann B. Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria. Antimicrob Agents Chemother. 1991 Oct;35(10):2031–2036. doi: 10.1128/aac.35.10.2031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Herrero M., Moreno F. Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli. J Gen Microbiol. 1986 Feb;132(2):393–402. doi: 10.1099/00221287-132-2-393. [DOI] [PubMed] [Google Scholar]
  61. Hiasa H., DiGate R. J., Marians K. J. Decatenating activity of Escherichia coli DNA gyrase and topoisomerases I and III during oriC and pBR322 DNA replication in vitro. J Biol Chem. 1994 Jan 21;269(3):2093–2099. [PubMed] [Google Scholar]
  62. Hiasa H., Marians K. J. Topoisomerase IV can support oriC DNA replication in vitro. J Biol Chem. 1994 Jun 10;269(23):16371–16375. [PubMed] [Google Scholar]
  63. Higgins C. F., Dorman C. J., Stirling D. A., Waddell L., Booth I. R., May G., Bremer E. A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli. Cell. 1988 Feb 26;52(4):569–584. doi: 10.1016/0092-8674(88)90470-9. [DOI] [PubMed] [Google Scholar]
  64. Hoshino K., Kitamura A., Morrissey I., Sato K., Kato J., Ikeda H. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob Agents Chemother. 1994 Nov;38(11):2623–2627. doi: 10.1128/aac.38.11.2623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Howard B. M., Pinney R. J., Smith J. T. 4-Quinolone bactericidal mechanisms. Arzneimittelforschung. 1993 Oct;43(10):1125–1129. [PubMed] [Google Scholar]
  66. Howard B. M., Pinney R. J., Smith J. T. Function of the SOS process in repair of DNA damage induced by modern 4-quinolones. J Pharm Pharmacol. 1993 Jul;45(7):658–662. doi: 10.1111/j.2042-7158.1993.tb05673.x. [DOI] [PubMed] [Google Scholar]
  67. Hsiang Y. H., Lihou M. G., Liu L. F. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 1989 Sep 15;49(18):5077–5082. [PubMed] [Google Scholar]
  68. Hsieh L. S., Burger R. M., Drlica K. Bacterial DNA supercoiling and [ATP]/[ADP]. Changes associated with a transition to anaerobic growth. J Mol Biol. 1991 Jun 5;219(3):443–450. doi: 10.1016/0022-2836(91)90185-9. [DOI] [PubMed] [Google Scholar]
  69. Hsieh L. S., Rouviere-Yaniv J., Drlica K. Bacterial DNA supercoiling and [ATP]/[ADP] ratio: changes associated with salt shock. J Bacteriol. 1991 Jun;173(12):3914–3917. doi: 10.1128/jb.173.12.3914-3917.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Hussain K., Elliott E. J., Salmond G. P. The parD- mutant of Escherichia coli also carries a gyrAam mutation. The complete sequence of gyrA. Mol Microbiol. 1987 Nov;1(3):259–273. doi: 10.1111/j.1365-2958.1987.tb01932.x. [DOI] [PubMed] [Google Scholar]
  71. Irbe R. M., Oishi M. Prophage induction in a permeabilized cell system: induction by deoxyribonucleases and the role of recBC-deoxyribonuclease. J Bacteriol. 1980 Dec;144(3):1061–1067. doi: 10.1128/jb.144.3.1061-1067.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Jensen P. R., Loman L., Petra B., van der Weijden C., Westerhoff H. V. Energy buffering of DNA structure fails when Escherichia coli runs out of substrate. J Bacteriol. 1995 Jun;177(12):3420–3426. doi: 10.1128/jb.177.12.3420-3426.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Kampranis S. C., Maxwell A. Conversion of DNA gyrase into a conventional type II topoisomerase. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14416–14421. doi: 10.1073/pnas.93.25.14416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Karem K., Foster J. W. The influence of DNA topology on the environmental regulation of a pH-regulated locus in Salmonella typhimurium. Mol Microbiol. 1993 Oct;10(1):75–86. doi: 10.1111/j.1365-2958.1993.tb00905.x. [DOI] [PubMed] [Google Scholar]
  75. Karu A. E., Belk E. D. Induction of E. coli recA protein via recBC and alternate pathways: quantitation by enzyme-linked immunosorbent assay (ELISA). Mol Gen Genet. 1982;185(2):275–282. doi: 10.1007/BF00330798. [DOI] [PubMed] [Google Scholar]
  76. Kato J., Nishimura Y., Imamura R., Niki H., Hiraga S., Suzuki H. New topoisomerase essential for chromosome segregation in E. coli. Cell. 1990 Oct 19;63(2):393–404. doi: 10.1016/0092-8674(90)90172-b. [DOI] [PubMed] [Google Scholar]
  77. Kato J., Nishimura Y., Yamada M., Suzuki H., Hirota Y. Gene organization in the region containing a new gene involved in chromosome partition in Escherichia coli. J Bacteriol. 1988 Sep;170(9):3967–3977. doi: 10.1128/jb.170.9.3967-3977.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Kato J., Suzuki H., Ikeda H. Purification and characterization of DNA topoisomerase IV in Escherichia coli. J Biol Chem. 1992 Dec 25;267(36):25676–25684. [PubMed] [Google Scholar]
  79. Khodursky A. B., Zechiedrich E. L., Cozzarelli N. R. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11801–11805. doi: 10.1073/pnas.92.25.11801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Kirkegaard K., Wang J. C. Mapping the topography of DNA wrapped around gyrase by nucleolytic and chemical probing of complexes of unique DNA sequences. Cell. 1981 Mar;23(3):721–729. doi: 10.1016/0092-8674(81)90435-9. [DOI] [PubMed] [Google Scholar]
  81. Kitamura A., Hoshino K., Kimura Y., Hayakawa I., Sato K. Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1995 Jul;39(7):1467–1471. doi: 10.1128/aac.39.7.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Klevan L., Wang J. C. Deoxyribonucleic acid gyrase-deoxyribonucleic acid complex containing 140 base pairs of deoxyribonucleic acid and an alpha 2 beta 2 protein core. Biochemistry. 1980 Nov 11;19(23):5229–5234. doi: 10.1021/bi00564a012. [DOI] [PubMed] [Google Scholar]
  83. Klopman G., Fercu D., Li J. Y., Rosenkranz H. S., Jacobs M. R. Antimycobacterial quinolones: a comparative analysis of structure-activity and structure-cytotoxicity relationships. Res Microbiol. 1996 Jan-Feb;147(1-2):86–96. doi: 10.1016/0923-2508(96)80209-9. [DOI] [PubMed] [Google Scholar]
  84. Krasin F., Hutchinson F. Repair of DNA double-strand breaks in Escherichia coli, which requires recA function and the presence of a duplicate genome. J Mol Biol. 1977 Oct 15;116(1):81–98. doi: 10.1016/0022-2836(77)90120-6. [DOI] [PubMed] [Google Scholar]
  85. Kreuzer K. N., Cozzarelli N. R. Escherichia coli mutants thermosensitive for deoxyribonucleic acid gyrase subunit A: effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth. J Bacteriol. 1979 Nov;140(2):424–435. doi: 10.1128/jb.140.2.424-435.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Kuemmerle N. B., Masker W. E. Effect of the uvrD mutation on excision repair. J Bacteriol. 1980 May;142(2):535–546. doi: 10.1128/jb.142.2.535-546.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Kushner S. R. Differential thermolability of exonuclease and endonuclease activities of the recBC nuclease isolated from thermosensitive recB and recC mutants. J Bacteriol. 1974 Dec;120(3):1219–1222. doi: 10.1128/jb.120.3.1219-1222.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Kuzminov A. Collapse and repair of replication forks in Escherichia coli. Mol Microbiol. 1995 May;16(3):373–384. doi: 10.1111/j.1365-2958.1995.tb02403.x. [DOI] [PubMed] [Google Scholar]
  89. Köppen A., Krobitsch S., Thoms B., Wackernagel W. Interaction with the recombination hot spot chi in vivo converts the RecBCD enzyme of Escherichia coli into a chi-independent recombinase by inactivation of the RecD subunit. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6249–6253. doi: 10.1073/pnas.92.14.6249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Lampe M. F., Bott K. F. Genetic and physical organization of the cloned gyrA and gyrB genes of Bacillus subtilis. J Bacteriol. 1985 Apr;162(1):78–84. doi: 10.1128/jb.162.1.78-84.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Lewin C. S., Amyes S. G., Smith J. T. Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16. Eur J Clin Microbiol Infect Dis. 1989 Aug;8(8):731–733. doi: 10.1007/BF01963763. [DOI] [PubMed] [Google Scholar]
  92. Lewin C. S., Amyes S. G. The bactericidal activity of DR-3355, an optically active isomer of ofloxacin. J Med Microbiol. 1989 Nov;30(3):227–231. doi: 10.1099/00222615-30-3-227. [DOI] [PubMed] [Google Scholar]
  93. Lewin C. S., Howard B. M., Ratcliffe N. T., Smith J. T. 4-quinolones and the SOS response. J Med Microbiol. 1989 Jun;29(2):139–144. doi: 10.1099/00222615-29-2-139. [DOI] [PubMed] [Google Scholar]
  94. Lewin C. S., Howard B. M., Smith J. T. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase. J Med Microbiol. 1991 Jan;34(1):19–22. doi: 10.1099/00222615-34-1-19. [DOI] [PubMed] [Google Scholar]
  95. Lewin C. S., Morrissey I., Smith J. T. The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis. J Pharm Pharmacol. 1991 Jul;43(7):492–494. doi: 10.1111/j.2042-7158.1991.tb03520.x. [DOI] [PubMed] [Google Scholar]
  96. Lewin C. S., Morrissey I., Smith J. T. The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment. Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):240–248. doi: 10.1007/BF01966996. [DOI] [PubMed] [Google Scholar]
  97. Lewin C. S., Smith J. T. Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens. J Med Microbiol. 1990 Jul;32(3):211–214. doi: 10.1099/00222615-32-3-211. [DOI] [PubMed] [Google Scholar]
  98. Lewin C. S., Smith J. T. DNA breakdown by the 4-quinolones and its significance. J Med Microbiol. 1990 Jan;31(1):65–70. doi: 10.1099/00222615-31-1-65. [DOI] [PubMed] [Google Scholar]
  99. Li L. H., Fraser T. J., Olin E. J., Bhuyan B. K. Action of camptothecin on mammalian cells in culture. Cancer Res. 1972 Dec;32(12):2643–2650. [PubMed] [Google Scholar]
  100. Little J. W. Mechanism of specific LexA cleavage: autodigestion and the role of RecA coprotease. Biochimie. 1991 Apr;73(4):411–421. doi: 10.1016/0300-9084(91)90108-d. [DOI] [PubMed] [Google Scholar]
  101. Lockshon D., Morris D. R. Sites of reaction of Escherichia coli DNA gyrase on pBR322 in vivo as revealed by oxolinic acid-induced plasmid linearization. J Mol Biol. 1985 Jan 5;181(1):63–74. doi: 10.1016/0022-2836(85)90324-9. [DOI] [PubMed] [Google Scholar]
  102. Luttinger A. L., Springer A. L., Schmid M. B. A cluster of genes that affects nucleoid segregation in Salmonella typhimurium. New Biol. 1991 Jul;3(7):687–697. [PubMed] [Google Scholar]
  103. Maki S., Takiguchi S., Horiuchi T., Sekimizu K., Miki T. Partner switching mechanisms in inactivation and rejuvenation of Escherichia coli DNA gyrase by F plasmid proteins LetD (CcdB) and LetA (CcdA). J Mol Biol. 1996 Mar 1;256(3):473–482. doi: 10.1006/jmbi.1996.0102. [DOI] [PubMed] [Google Scholar]
  104. Maki S., Takiguchi S., Miki T., Horiuchi T. Modulation of DNA supercoiling activity of Escherichia coli DNA gyrase by F plasmid proteins. Antagonistic actions of LetA (CcdA) and LetD (CcdB) proteins. J Biol Chem. 1992 Jun 15;267(17):12244–12251. [PubMed] [Google Scholar]
  105. Malik M., Bensaid A., Rouviere-Yaniv J., Drlica K. Histone-like protein HU and bacterial DNA topology: suppression of an HU deficiency by gyrase mutations. J Mol Biol. 1996 Feb 16;256(1):66–76. doi: 10.1006/jmbi.1996.0068. [DOI] [PubMed] [Google Scholar]
  106. Manes S. H., Pruss G. J., Drlica K. Inhibition of RNA synthesis by oxolinic acid is unrelated to average DNA supercoiling. J Bacteriol. 1983 Jul;155(1):420–423. doi: 10.1128/jb.155.1.420-423.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. McCoy E. C., Petrullo L. A., Rosenkranz H. S. Non-mutagenic genotoxicants: novobiocin and nalidixic acid, 2 inhibitors of DNA gyrase. Mutat Res. 1980 Sep;79(1):33–43. doi: 10.1016/0165-1218(80)90145-7. [DOI] [PubMed] [Google Scholar]
  108. McDaniel L. S., Rogers L. H., Hill W. E. Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid. J Bacteriol. 1978 Jun;134(3):1195–1198. doi: 10.1128/jb.134.3.1195-1198.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. McNairn E., Ni Bhriain N., Dorman C. J. Overexpression of the Shigella flexneri genes coding for DNA topoisomerase IV compensates for loss of DNA topoisomerase I: effect on virulence gene expression. Mol Microbiol. 1995 Feb;15(3):507–517. doi: 10.1111/j.1365-2958.1995.tb02264.x. [DOI] [PubMed] [Google Scholar]
  110. McPartland A., Green L., Echols H. Control of recA gene RNA in E. coli: regulatory and signal genes. Cell. 1980 Jul;20(3):731–737. doi: 10.1016/0092-8674(80)90319-0. [DOI] [PubMed] [Google Scholar]
  111. Menzel R., Gellert M. Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling. Cell. 1983 Aug;34(1):105–113. doi: 10.1016/0092-8674(83)90140-x. [DOI] [PubMed] [Google Scholar]
  112. Miki T., Park J. A., Nagao K., Murayama N., Horiuchi T. Control of segregation of chromosomal DNA by sex factor F in Escherichia coli. Mutants of DNA gyrase subunit A suppress letD (ccdB) product growth inhibition. J Mol Biol. 1992 May 5;225(1):39–52. doi: 10.1016/0022-2836(92)91024-j. [DOI] [PubMed] [Google Scholar]
  113. Miki T., Yoshioka K., Horiuchi T. Control of cell division by sex factor F in Escherichia coli. I. The 42.84-43.6 F segment couples cell division of the host bacteria with replication of plasmid DNA. J Mol Biol. 1984 Apr 25;174(4):605–625. doi: 10.1016/0022-2836(84)90086-x. [DOI] [PubMed] [Google Scholar]
  114. Mizushima T., Natori S., Sekimizu K. Relaxation of supercoiled DNA associated with induction of heat shock proteins in Escherichia coli. Mol Gen Genet. 1993 Apr;238(1-2):1–5. doi: 10.1007/BF00279523. [DOI] [PubMed] [Google Scholar]
  115. Mojica F. J., Charbonnier F., Juez G., Rodríguez-Valera F., Forterre P. Effects of salt and temperature on plasmid topology in the halophilic archaeon Haloferax volcanii. J Bacteriol. 1994 Aug;176(16):4966–4973. doi: 10.1128/jb.176.16.4966-4973.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Moreau N. J., Robaux H., Baron L., Tabary X. Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. Antimicrob Agents Chemother. 1990 Oct;34(10):1955–1960. doi: 10.1128/aac.34.10.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Morrison A., Cozzarelli N. R. Contacts between DNA gyrase and its binding site on DNA: features of symmetry and asymmetry revealed by protection from nucleases. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1416–1420. doi: 10.1073/pnas.78.3.1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Morrison A., Higgins N. P., Cozzarelli N. R. Interaction between DNA gyrase and its cleavage site on DNA. J Biol Chem. 1980 Mar 10;255(5):2211–2219. [PubMed] [Google Scholar]
  119. Morrissey I., Smith J. T. The importance of oxygen in the killing of bacteria by ofloxacin and ciprofloxacin. Microbios. 1994;79(318):43–53. [PubMed] [Google Scholar]
  120. Murayama N., Shimizu H., Takiguchi S., Baba Y., Amino H., Horiuchi T., Sekimizu K., Miki T. Evidence for involvement of Escherichia coli genes pmbA, csrA and a previously unrecognized gene tldD, in the control of DNA gyrase by letD (ccdB) of sex factor F. J Mol Biol. 1996 Mar 1;256(3):483–502. doi: 10.1006/jmbi.1996.0103. [DOI] [PubMed] [Google Scholar]
  121. Muñoz R., De La Campa A. G. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob Agents Chemother. 1996 Oct;40(10):2252–2257. doi: 10.1128/aac.40.10.2252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Myers R. S., Kuzminov A., Stahl F. W. The recombination hot spot chi activates RecBCD recombination by converting Escherichia coli to a recD mutant phenocopy. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6244–6248. doi: 10.1073/pnas.92.14.6244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Myers R. S., Stahl F. W. Chi and the RecBC D enzyme of Escherichia coli. Annu Rev Genet. 1994;28:49–70. doi: 10.1146/annurev.ge.28.120194.000405. [DOI] [PubMed] [Google Scholar]
  124. Nakamura S., Nakamura M., Kojima T., Yoshida H. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother. 1989 Feb;33(2):254–255. doi: 10.1128/aac.33.2.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Ng E. Y., Trucksis M., Hooper D. C. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob Agents Chemother. 1996 Aug;40(8):1881–1888. doi: 10.1128/aac.40.8.1881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Nitiss J., Wang J. C. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7501–7505. doi: 10.1073/pnas.85.20.7501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Oishi M., Smith C. L., Friefeld B. Molecular events and molecules that lead to induction of prophage and SOS functions. Cold Spring Harb Symp Quant Biol. 1979;43(Pt 2):897–907. doi: 10.1101/sqb.1979.043.01.098. [DOI] [PubMed] [Google Scholar]
  128. Oppegaard H., Sørum H. gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida. Antimicrob Agents Chemother. 1994 Oct;38(10):2460–2464. doi: 10.1128/aac.38.10.2460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Oram M., Fisher L. M. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob Agents Chemother. 1991 Feb;35(2):387–389. doi: 10.1128/aac.35.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Orphanides G., Maxwell A. Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl radical footprinting. Nucleic Acids Res. 1994 May 11;22(9):1567–1575. doi: 10.1093/nar/22.9.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Orr E., Fairweather N. F., Holland I. B., Pritchard R. H. Isolation and characterisation of a strain carrying a conditional lethal mutation in the cou gene of Escherichia coli K12. Mol Gen Genet. 1979;177(1):103–112. doi: 10.1007/BF00267259. [DOI] [PubMed] [Google Scholar]
  132. Ouabdesselam S., Hooper D. C., Tankovic J., Soussy C. J. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Antimicrob Agents Chemother. 1995 Aug;39(8):1667–1670. doi: 10.1128/aac.39.8.1667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Pan X. S., Ambler J., Mehtar S., Fisher L. M. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996 Oct;40(10):2321–2326. doi: 10.1128/aac.40.10.2321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Pan X. S., Fisher L. M. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J Bacteriol. 1996 Jul;178(14):4060–4069. doi: 10.1128/jb.178.14.4060-4069.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Pan X. S., Fisher L. M. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob Agents Chemother. 1997 Feb;41(2):471–474. doi: 10.1128/aac.41.2.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Pato M. L. Central location of the Mu strong gyrase binding site is obligatory for optimal rates of replicative transposition. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7056–7060. doi: 10.1073/pnas.91.15.7056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Pato M. L., Howe M. M., Higgins N. P. A DNA gyrase-binding site at the center of the bacteriophage Mu genome is required for efficient replicative transposition. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8716–8720. doi: 10.1073/pnas.87.22.8716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Pato M. L., Karlok M., Wall C., Higgins N. P. Characterization of Mu prophage lacking the central strong gyrase binding site: localization of the block in replication. J Bacteriol. 1995 Oct;177(20):5937–5942. doi: 10.1128/jb.177.20.5937-5942.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Peng H., Marians K. J. Decatenation activity of topoisomerase IV during oriC and pBR322 DNA replication in vitro. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8571–8575. doi: 10.1073/pnas.90.18.8571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Peng H., Marians K. J. Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions. J Biol Chem. 1993 Nov 15;268(32):24481–24490. [PubMed] [Google Scholar]
  141. Peng H., Marians K. J. The interaction of Escherichia coli topoisomerase IV with DNA. J Biol Chem. 1995 Oct 20;270(42):25286–25290. doi: 10.1074/jbc.270.42.25286. [DOI] [PubMed] [Google Scholar]
  142. Phillips I., Culebras E., Moreno F., Baquero F. Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother. 1987 Nov;20(5):631–638. doi: 10.1093/jac/20.5.631. [DOI] [PubMed] [Google Scholar]
  143. Power E. G., Phillips I. Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents. FEMS Microbiol Lett. 1993 Sep 15;112(3):251–254. doi: 10.1111/j.1574-6968.1993.tb06458.x. [DOI] [PubMed] [Google Scholar]
  144. Power E. G., Phillips I. Induction of the SOS gene (umuC) by 4-quinolone antibacterial drugs. J Med Microbiol. 1992 Feb;36(2):78–82. doi: 10.1099/00222615-36-2-78. [DOI] [PubMed] [Google Scholar]
  145. Pruss G. J., Franco R. J., Chevalier S. G., Manes S. H., Drlica K. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants. J Bacteriol. 1986 Oct;168(1):276–282. doi: 10.1128/jb.168.1.276-282.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Pruss G. J., Manes S. H., Drlica K. Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes. Cell. 1982 Nov;31(1):35–42. doi: 10.1016/0092-8674(82)90402-0. [DOI] [PubMed] [Google Scholar]
  147. Rahman M., Mauff G., Levy J., Couturier M., Pulverer G., Glasdorff N., Butzler J. P. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob Agents Chemother. 1994 Oct;38(10):2488–2491. doi: 10.1128/aac.38.10.2488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Raji A., Zabel D. J., Laufer C. S., Depew R. E. Genetic analysis of mutations that compensate for loss of Escherichia coli DNA topoisomerase I. J Bacteriol. 1985 Jun;162(3):1173–1179. doi: 10.1128/jb.162.3.1173-1179.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Rau D. C., Gellert M., Thoma F., Maxwell A. Structure of the DNA gyrase-DNA complex as revealed by transient electric dichroism. J Mol Biol. 1987 Feb 5;193(3):555–569. doi: 10.1016/0022-2836(87)90266-x. [DOI] [PubMed] [Google Scholar]
  150. Reece R. J., Maxwell A. DNA gyrase: structure and function. Crit Rev Biochem Mol Biol. 1991;26(3-4):335–375. doi: 10.3109/10409239109114072. [DOI] [PubMed] [Google Scholar]
  151. Revel-Viravau V., Truong Q. C., Moreau N., Jarlier V., Sougakoff W. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis. Antimicrob Agents Chemother. 1996 Sep;40(9):2054–2061. doi: 10.1128/aac.40.9.2054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Revel V., Cambau E., Jarlier V., Sougakoff W. Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones. Antimicrob Agents Chemother. 1994 Sep;38(9):1991–1996. doi: 10.1128/aac.38.9.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Reyna F., Huesca M., González V., Fuchs L. Y. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob Agents Chemother. 1995 Jul;39(7):1621–1623. doi: 10.1128/aac.39.7.1621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Richardson S. M., Higgins C. F., Lilley D. M. The genetic control of DNA supercoiling in Salmonella typhimurium. EMBO J. 1984 Aug;3(8):1745–1752. doi: 10.1002/j.1460-2075.1984.tb02041.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Roca J. The mechanisms of DNA topoisomerases. Trends Biochem Sci. 1995 Apr;20(4):156–160. doi: 10.1016/s0968-0004(00)88993-8. [DOI] [PubMed] [Google Scholar]
  156. Roca J., Wang J. C. DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism. Cell. 1994 May 20;77(4):609–616. doi: 10.1016/0092-8674(94)90222-4. [DOI] [PubMed] [Google Scholar]
  157. Roca J., Wang J. C. The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases. Cell. 1992 Nov 27;71(5):833–840. doi: 10.1016/0092-8674(92)90558-t. [DOI] [PubMed] [Google Scholar]
  158. Rodríguez-Sáinz M. C., Hernández-Chico C., Moreno F. Molecular characterization of pmbA, an Escherichia coli chromosomal gene required for the production of the antibiotic peptide MccB17. Mol Microbiol. 1990 Nov;4(11):1921–1932. doi: 10.1111/j.1365-2958.1990.tb02041.x. [DOI] [PubMed] [Google Scholar]
  159. San Millan J. L., Hernandez-Chico C., Pereda P., Moreno F. Cloning and mapping of the genetic determinants for microcin B17 production and immunity. J Bacteriol. 1985 Jul;163(1):275–281. doi: 10.1128/jb.163.1.275-281.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. San Millán J. L., Kolter R., Moreno F. Evidence that colicin X is microcin B17. J Bacteriol. 1987 Jun;169(6):2899–2901. doi: 10.1128/jb.169.6.2899-2901.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Sanchez J. P., Gogliotti R. D., Domagala J. M., Gracheck S. J., Huband M. D., Sesnie J. A., Cohen M. A., Shapiro M. A. The synthesis, structure-activity, and structure-side effect relationships of a series of 8-alkoxy- and 5-amino-8-alkoxyquinolone antibacterial agents. J Med Chem. 1995 Oct 27;38(22):4478–4487. doi: 10.1021/jm00022a013. [DOI] [PubMed] [Google Scholar]
  162. Schmid M. B. A locus affecting nucleoid segregation in Salmonella typhimurium. J Bacteriol. 1990 Sep;172(9):5416–5424. doi: 10.1128/jb.172.9.5416-5424.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Shen L. L., Baranowski J., Pernet A. G. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA. Biochemistry. 1989 May 2;28(9):3879–3885. doi: 10.1021/bi00435a038. [DOI] [PubMed] [Google Scholar]
  164. Shen L. L., Kohlbrenner W. E., Weigl D., Baranowski J. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. J Biol Chem. 1989 Feb 15;264(5):2973–2978. [PubMed] [Google Scholar]
  165. Shen L. L., Mitscher L. A., Sharma P. N., O'Donnell T. J., Chu D. W., Cooper C. S., Rosen T., Pernet A. G. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model. Biochemistry. 1989 May 2;28(9):3886–3894. doi: 10.1021/bi00435a039. [DOI] [PubMed] [Google Scholar]
  166. Shen L. L., Pernet A. G. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA. Proc Natl Acad Sci U S A. 1985 Jan;82(2):307–311. doi: 10.1073/pnas.82.2.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Shimizu H., Yamaguchi H., Ikeda H. Molecular analysis of lambda bio transducing phage produced by oxolinic acid-induced illegitimate recombination in vivo. Genetics. 1995 Jul;140(3):889–896. doi: 10.1093/genetics/140.3.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Shishido K., Komiyama N., Ikawa S. Increased production of a knotted form of plasmid pBR322 DNA in Escherichia coli DNA topoisomerase mutants. J Mol Biol. 1987 May 5;195(1):215–218. doi: 10.1016/0022-2836(87)90338-x. [DOI] [PubMed] [Google Scholar]
  169. Slilaty S. N., Rupley J. A., Little J. W. Intramolecular cleavage of LexA and phage lambda repressors: dependence of kinetics on repressor concentration, pH, temperature, and solvent. Biochemistry. 1986 Nov 4;25(22):6866–6875. doi: 10.1021/bi00370a020. [DOI] [PubMed] [Google Scholar]
  170. Smith G. R. Homologous recombination in procaryotes. Microbiol Rev. 1988 Mar;52(1):1–28. doi: 10.1128/mr.52.1.1-28.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Snyder M., Drlica K. DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid. J Mol Biol. 1979 Jun 25;131(2):287–302. doi: 10.1016/0022-2836(79)90077-9. [DOI] [PubMed] [Google Scholar]
  172. Sommer S., Bailone A., Devoret R. SOS induction by thermosensitive replication mutants of miniF plasmid. Mol Gen Genet. 1985;198(3):456–464. doi: 10.1007/BF00332939. [DOI] [PubMed] [Google Scholar]
  173. Soussy C. J., Wolfson J. S., Ng E. Y., Hooper D. C. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus. Antimicrob Agents Chemother. 1993 Dec;37(12):2588–2592. doi: 10.1128/aac.37.12.2588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Steck T. R., Drlica K. Bacterial chromosome segregation: evidence for DNA gyrase involvement in decatenation. Cell. 1984 Apr;36(4):1081–1088. doi: 10.1016/0092-8674(84)90058-8. [DOI] [PubMed] [Google Scholar]
  175. Steck T. R., Pruss G. J., Manes S. H., Burg L., Drlica K. DNA supercoiling in gyrase mutants. J Bacteriol. 1984 May;158(2):397–403. doi: 10.1128/jb.158.2.397-403.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Stewart P. S., D'Ari R. Genetic and morphological characterization of an Escherichia coli chromosome segregation mutant. J Bacteriol. 1992 Jul;174(13):4513–4516. doi: 10.1128/jb.174.13.4513-4516.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Sugino A., Higgins N. P., Brown P. O., Peebles C. L., Cozzarelli N. R. Energy coupling in DNA gyrase and the mechanism of action of novobiocin. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4838–4842. doi: 10.1073/pnas.75.10.4838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Sugino A., Peebles C. L., Kreuzer K. N., Cozzarelli N. R. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci U S A. 1977 Nov;74(11):4767–4771. doi: 10.1073/pnas.74.11.4767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Takenouchi T., Ishii C., Sugawara M., Tokue Y., Ohya S. Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones. Antimicrob Agents Chemother. 1995 Jul;39(7):1414–1418. doi: 10.1128/aac.39.7.1414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Takiff H. E., Salazar L., Guerrero C., Philipp W., Huang W. M., Kreiswirth B., Cole S. T., Jacobs W. R., Jr, Telenti A. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother. 1994 Apr;38(4):773–780. doi: 10.1128/aac.38.4.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Trucksis M., Wolfson J. S., Hooper D. C. A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus. J Bacteriol. 1991 Sep;173(18):5854–5860. doi: 10.1128/jb.173.18.5854-5860.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Tsao Y. P., Russo A., Nyamuswa G., Silber R., Liu L. F. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res. 1993 Dec 15;53(24):5908–5914. [PubMed] [Google Scholar]
  183. Urios A., Herrera G., Aleixandre V., Blanco M. Influence of recA mutations on gyrA dependent quinolone resistance. Biochimie. 1991 Apr;73(4):519–521. doi: 10.1016/0300-9084(91)90123-i. [DOI] [PubMed] [Google Scholar]
  184. Vila J., Ruiz J., Goñi P., De Anta M. T. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother. 1996 Feb;40(2):491–493. doi: 10.1128/aac.40.2.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Vizán J. L., Hernández-Chico C., del Castillo I., Moreno F. The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase. EMBO J. 1991 Feb;10(2):467–476. doi: 10.1002/j.1460-2075.1991.tb07969.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Volff J. N., Vandewiele D., Decaris B. Stimulation of genetic instability and associated large genomic rearrangements in Streptomyces ambofaciens by three fluoroquinolones. Antimicrob Agents Chemother. 1994 Sep;38(9):1984–1990. doi: 10.1128/aac.38.9.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Walker G. C. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol Rev. 1984 Mar;48(1):60–93. doi: 10.1128/mr.48.1.60-93.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Westerhoff H. V., O'Dea M. H., Maxwell A., Gellert M. DNA supercoiling by DNA gyrase. A static head analysis. Cell Biophys. 1988 Jan-Jun;12:157–181. doi: 10.1007/BF02918357. [DOI] [PubMed] [Google Scholar]
  189. Willetts N. S., Clark A. J. Characteristics of some multiply recombination-deficient strains of Escherichia coli. J Bacteriol. 1969 Oct;100(1):231–239. doi: 10.1128/jb.100.1.231-239.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Willmott C. J., Critchlow S. E., Eperon I. C., Maxwell A. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. J Mol Biol. 1994 Sep 30;242(4):351–363. doi: 10.1006/jmbi.1994.1586. [DOI] [PubMed] [Google Scholar]
  191. Winshell E. B., Rosenkranz H. S. Nalidixic Acid and the Metabolism of Escherichia coli. J Bacteriol. 1970 Dec;104(3):1168–1175. doi: 10.1128/jb.104.3.1168-1175.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Worcel A., Burgi E. On the structure of the folded chromosome of Escherichia coli. J Mol Biol. 1972 Nov 14;71(2):127–147. doi: 10.1016/0022-2836(72)90342-7. [DOI] [PubMed] [Google Scholar]
  193. Xu C., Kreiswirth B. N., Sreevatsan S., Musser J. M., Drlica K. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis. J Infect Dis. 1996 Nov;174(5):1127–1130. doi: 10.1093/infdis/174.5.1127. [DOI] [PubMed] [Google Scholar]
  194. Yamagishi J., Kojima T., Oyamada Y., Fujimoto K., Hattori H., Nakamura S., Inoue M. Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1996 May;40(5):1157–1163. doi: 10.1128/aac.40.5.1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Yamagishi J., Yoshida H., Yamayoshi M., Nakamura S. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen Genet. 1986 Sep;204(3):367–373. doi: 10.1007/BF00331012. [DOI] [PubMed] [Google Scholar]
  196. Yang S. W., Burgin A. B., Jr, Huizenga B. N., Robertson C. A., Yao K. C., Nash H. A. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11534–11539. doi: 10.1073/pnas.93.21.11534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Yoshida H., Bogaki M., Nakamura M., Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother. 1990 Jun;34(6):1271–1272. doi: 10.1128/aac.34.6.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Yoshida H., Bogaki M., Nakamura M., Yamanaka L. M., Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother. 1991 Aug;35(8):1647–1650. doi: 10.1128/aac.35.8.1647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Yoshida H., Kojima T., Yamagishi J., Nakamura S. Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol Gen Genet. 1988 Jan;211(1):1–7. doi: 10.1007/BF00338386. [DOI] [PubMed] [Google Scholar]
  200. Zabinski R. A., Walker K. J., Larsson A. J., Moody J. A., Kaatz G. W., Rotschafer J. C. Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones. Antimicrob Agents Chemother. 1995 Feb;39(2):507–512. doi: 10.1128/aac.39.2.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Zechiedrich E. L., Cozzarelli N. R. Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in Escherichia coli. Genes Dev. 1995 Nov 15;9(22):2859–2869. doi: 10.1101/gad.9.22.2859. [DOI] [PubMed] [Google Scholar]
  202. Zechiedrich E. L., Osheroff N. Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers. EMBO J. 1990 Dec;9(13):4555–4562. doi: 10.1002/j.1460-2075.1990.tb07908.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. von Wright A., Bridges B. A. Effect of gyrB-mediated changes in chromosome structure on killing of Escherichia coli by ultraviolet light: experiments with strains differing in deoxyribonucleic acid repair capacity. J Bacteriol. 1981 Apr;146(1):18–23. doi: 10.1128/jb.146.1.18-23.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Microbiology and Molecular Biology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES